Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reexamination Certificate
2011-08-16
2011-08-16
Haghighatian, Mina (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C424S046000, C424S043000, C424S434000
Reexamination Certificate
active
07998463
ABSTRACT:
An anti-tussive nebulized solution for targeted delivery of lidocaine into conducting and central airways. A method for treatment of cough and tussive attacks or episodes using said lidocaine solution. A nebulized lidocaine solution administered in daily dose from about 10 mg to 80 mg of lidocaine dissolved in a saline and nebulized into an aerosol having a mass median aerodynamic diameter 3 μm to 10 μm and a geometric standard deviation less than 1.7 using an electronic nebulizer.
REFERENCES:
patent: 2003/0171402 (2003-09-01), Gleich et al.
patent: 2003/0232019 (2003-12-01), Basu et al.
patent: 2009/0004279 (2009-01-01), Hofmann et al.
Emmanuel Udezue, Lidocaine inhalation for Cough Suppression, Clinical Notes, pp. 206-207, Oct. 2000.
M. L. Decco, et al., Nebulized Lidocaine in the Treatment of Severe Asthma in Children: a Pilot Study,Annals of Allergy, Asthma&Immunology, V.82, No. 1, Jan. 1, 1999, Arlington Heights, IL, USA.
Loren W. Hunt, et al. Effect of Nebulized Lidocaine on Severe Glucocorticoid-Dependent Asthma,Mayo Clin Proc, 71:361-368 (1996).
PARI's eFlow(R), an Electronic Aerosol Device for Medication Delivery, Receives FDA 510(k) Market Clearance,PARI Serosol Research Institute, pp. 1-2; May 18, 2004, Monterey, California, USA.
European Supplemental Search Report, European Patent Office, Dec. 16, 2009.
Abuan, Tammy B.S.N., Inhaled Lidocaine for the Treatment of Asthma: Lack of Efficacy in Two Double-Blind, Randomized, Placebo-Controlled Clinical Studies, Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 23/6, pp. 381-388, 2010.
Iacono, Aldo T., et al., Dose-Related Reversal of Acute Lung Rejection by Aersolized Cyclosporine, Am J Respir CrIt Care Med, vol. 155, pp. 1690-1698, (1997).
Poulton, Thomas J., M.D., et al., Cough suppression by Lidocaine, Anesthesiology, vol. 50/5, pp. 470-472, May 1979.
Sanders, Robert F., et al., Prolonged Suppression of Cough After Inhalation of Lidocaine in a Patient With Sarcoid, JAMA, vol. 252/17; pp. 2456-2457, Nov. 2, 1984.
Sherman, James M., Breaking the Cycle: Lidocaine Therapy for Habit Cough, J. Florida M.A., vol. 84/5, pp. 308-309, Jun./Jul. 1997.
Trochtenberg, S., Nebulized lidocaine in the treatment of refractory cough, Chest, 105:1592-1593, 1994.
Hofmann Thomas
Montgomery Alan Bruce
Stapleton Kevin
Gilead Sciences, Inc.
Haghighatian Mina
Peters Verny LLP
LandOfFree
Targeted delivery of lidocaine and other local anesthetics... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted delivery of lidocaine and other local anesthetics..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted delivery of lidocaine and other local anesthetics... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2728448